Jordan B. King et al. JCHF 2016;4:

Slides:



Advertisements
Similar presentations
This presentation reflects the views of the presenter and does not necessarily reflect the views of the American College of Cardiology Content Distributed.
Advertisements

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Time to Cost-Effectiveness Following Stroke Reduction.
From: Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction.
Volume 18, Issue 2, Pages (March 2015)
Markov model structure
Pablo Ávila et al. JACEP 2015;1:
Dean J. Kereiakes et al. JACC 2017;70:
Orly Vardeny et al. JCHF 2014;2:
G. Michael Felker et al. JCHF 2014;2:
Kenshi Hayashi et al. JACEP 2016;2:
Carolyn Y. Ho et al. JCHF 2015;3:
Caroline Zotter-Tufaro et al. JCHF 2015;3:
Belinda Gray et al. JCHF 2013;1:
Pablo B. Nery et al. JACEP 2016;2:
Patrick M. Boyle et al. JACEP 2018;4:
Wayne L. Miller et al. JCHF 2013;1:
Prakash Harikrishnan et al. JACEP 2015;1:
G. Michael Felker et al. JCHF 2014;2:
Svend A. Mortensen et al. JCHF 2014;2:
Relative risks of clinical events for primary and secondary prevention with selected drugs Thomas A Gaziano, et al. Lancet 2006; 368:
S.M. Afzal Sohaib et al. JACEP 2015;1:
Yoshitaka Kimura et al. JACEP 2016;2:
Ivan C. Gerling et al. JCHF 2013;1:
Emilce Trucco et al. JACEP 2018;j.jacep
Marwan Badri et al. JACEP 2015;1:
Kenshi Hayashi et al. JACEP 2016;2:
Connie W. Tsao et al. JCHF 2016;4:
Rami Doukky et al. JCHF 2016;4:24-35
Jennifer T. Thibodeau et al. JCHF 2014;2:24-31
Neal A. Chatterjee et al. JCHF 2014;2:
P. Michael Grossman et al. JCIN 2009;2:
Moussa Mansour et al. JACEP 2016;j.jacep
Gordon R. Reeves et al. JCHF 2017;j.jchf
William T. Abraham et al. JCHF 2015;3:
Peter E. Carson et al. JCHF 2015;3:
Maria R. Costanzo et al. JCHF 2016;4:
Ayman A. Hussein et al. JACEP 2017;3:1-9
Jennifer T. Thibodeau et al. JCHF 2014;2:24-31
S.M. Afzal Sohaib et al. JACEP 2015;1:
Rami Doukky et al. JCHF 2016;4:24-35
Björn Redfors et al. JACEP 2017;j.jacep
Adam B. Greenbaum et al. JACEP 2015;1:
John Rickard et al. JCHF 2013;1:
Jacqueline Baras Shreibati et al. JCHF 2017;j.jchf
Miyako Igarashi et al. JACEP 2018;4:
Leo F. Buckley et al. JCHF 2016;4:1-8
Maria Rosa Costanzo et al. JCHF 2016;4:95-105
Jeffrey L. Anderson et al. JACC 2007;50:e1-e157
Jordan B. King et al. JCHF 2016;4:
Svend A. Mortensen et al. JCHF 2014;2:
Natasha A. Loghmanpour et al. JCHF 2016;4:
Davide Capodanno et al. JCIN 2009;2:
Khadijah Breathett et al. JCHF 2017;5:
Connie W. Tsao et al. JCHF 2016;4:
Jeffrey J. Teuteberg et al. JCHF 2015;3:
Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:
Ryan R. Reeves et al. JCIN 2015;8:
Christian Madelaire et al. JCHF 2018;6:
Satoru Kishi et al. JCHF 2014;2:
Khadijah Breathett et al. JCHF 2017;5:
Constantijn Franssen et al. JCHF 2016;4:
Dennis M. McNamara et al. JCHF 2014;2:
Zeenat Safdar et al. JCHF 2014;2:
Zeenat Safdar et al. JCHF 2014;2:
John J.V. McMurray et al. JCHF 2018;6:8-17
Jackson J. Liang et al. JCHF 2014;2:
Orly Vardeny et al. JCHF 2016;4:
Maria R. Costanzo et al. JCHF 2016;4:
Probabilistic sensitivity analysis.
Constantijn Franssen et al. JCHF 2016;4:
Presentation transcript:

Jordan B. King et al. JCHF 2016;4:392-402 ScatterPlot of Incremental Costs and Incremental QALYs Over a Lifetime for Sacubitril-Valsartan Relative to Enalapril Probabilistic sensitivity analysis results of 10,000 model simulations. Results reflect the effect of uncertainty in the model on differences in costs and quality-adjusted life-years (QALYs) for patients taking sacubitril-valsartan relative to those taking enalapril. Jordan B. King et al. JCHF 2016;4:392-402 American College of Cardiology Foundation